Umeclidinium Brm/Vilanterol Tr
Brand name: Anoro Ellipta
Rank #60 of 500 drugs by total cost
$294.3M
Total Cost
480,651
Total Claims
$294.3M
Total Cost
14,990
Prescribers
$612
Cost per Claim
56,085
Beneficiaries
615,019
30-Day Fills
$20K
Avg Cost/Provider
32
Avg Claims/Provider
About Umeclidinium Brm/Vilanterol Tr
Umeclidinium Brm/Vilanterol Tr (sold as Anoro Ellipta) was prescribed 480,651 times by 14,990 Medicare Part D providers in 2023, costing the program $294.3M. At $612 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 57 | Rifaximin (Xifaxan) | $310.0M | 111,328 |
| 58 | Sitagliptin Phos/Metformin Hcl (Janumet) | $302.2M | 329,315 |
| 59 | Tofacitinib Citrate (Xeljanz Xr) | $294.4M | 49,478 |
| 60 | Umeclidinium Brm/Vilanterol Tr (Anoro Ellipta) | $294.3M | 480,651 |
| 61 | Gabapentin (Gabapentin) | $291.0M | 15,142,335 |
| 62 | Cabozantinib S-Malate (Cabometyx) | $287.3M | 11,285 |
| 63 | Rsv Vacc, Pref A And Pref B/Pf (Abrysvo) | $284.5M | 872,396 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology